Arbutus Biopharma Corp - Common Shares, without par value (ABUS)

CUSIP: 03879J100

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Shares, without par value
Shares outstanding
197,420,670
Total 13F shares
54,227,682
Share change
+7,423,842
Total reported value
$126,382,359
Put/Call ratio
57%
Price per share
$2.33
Number of holders
110
Value change
+$17,821,528
Number of buys
56
Number of sells
48

Security key

03879J100

Report period

Q4 2022

Institutions

110

Top holders

10

Top shareholders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
3.8%
7,467,818
$14,264,000 30 Sep 2022
13F
Two Seas Capital LP
13F
Company
2.9%
5,653,917
$10,799,000 30 Sep 2022
13F
VANGUARD GROUP INC
13F
Company
2.7%
5,265,884
$10,058,000 30 Sep 2022
13F
Hudson Bay Capital Management LP
13F
Company
2.5%
4,961,895
$9,477,000 30 Sep 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.8%
3,510,188
$6,704,000 30 Sep 2022
13F
STATE STREET CORP
13F
Company
1%
2,011,376
$3,842,000 30 Sep 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1%
2,009,840
$3,838,000 30 Sep 2022
13F
FourWorld Capital Management LLC
13F
Company
1%
2,000,090
$3,820,000 30 Sep 2022
13F
Assenagon Asset Management S.A.
13F
Company
0.96%
1,895,161
$3,620,000 30 Sep 2022
13F
OSAIC HOLDINGS, INC.
13F
Company
0.69%
1,364,523
$2,606,000 30 Sep 2022
13F
Oasis Management Co Ltd.
13F
Company
0.52%
1,026,672
$1,961,000 30 Sep 2022
13F
NORTHERN TRUST CORP
13F
Company
0.46%
900,547
$1,720,000 30 Sep 2022
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.39%
767,400
$1,466,000 30 Sep 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.33%
651,036
$1,243,000 30 Sep 2022
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.22%
433,564
$828,000 30 Sep 2022
13F
PRIMECAP MANAGEMENT CO/CA/
13F
Company
0.21%
423,300
$809,000 30 Sep 2022
13F
MARSHALL WACE, LLP
13F
Company
0.2%
392,932
$751,000 30 Sep 2022
13F
Bank of New York Mellon Corp
13F
Company
0.2%
385,460
$736,000 30 Sep 2022
13F
Nuveen Asset Management, LLC
13F
Company
0.17%
326,140
$623,000 30 Sep 2022
13F
BANK OF MONTREAL /CAN/
13F
Company
0.16%
320,003
$707,000 30 Sep 2022
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.15%
289,562
$553,000 30 Sep 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.15%
287,419
$549,000 30 Sep 2022
13F
Deutsche Girozentrale DekaBank
13F
Individual
0.13%
250,000
$485,000 30 Sep 2022
13F
JACOB ASSET MANAGEMENT OF NEW YORK LLC
13F
Company
0.11%
220,000
$420,000 30 Sep 2022
13F
MORGAN STANLEY
13F
Company
0.11%
211,992
$405,000 30 Sep 2022
13F
Parallax Volatility Advisers, L.P.
13F
Company
0.1%
200,528
$383,000 30 Sep 2022
13F
Kepos Capital LP
13F
Company
0.1%
200,000
$382,000 30 Sep 2022
13F
CITADEL ADVISORS LLC
13F
Company
0.1%
187,759
$358,000 30 Sep 2022
13F
FMR LLC
13F
Company
0.09%
186,776
$357,000 30 Sep 2022
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.09%
183,867
$351,000 30 Sep 2022
13F
RHUMBLINE ADVISERS
13F
Company
0.07%
142,840
$273,000 30 Sep 2022
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.07%
136,300
$260,000 30 Sep 2022
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.05%
94,800
$181,000 30 Sep 2022
13F
ROYAL BANK OF CANADA
13F
Company
0.05%
92,523
$177,000 30 Sep 2022
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.05%
90,497
$173,000 30 Sep 2022
13F
Man Group plc
13F
Company
0.04%
87,246
$167,000 30 Sep 2022
13F
ALPS ADVISORS INC
13F
Company
0.04%
81,878
$156,000 30 Sep 2022
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.04%
75,476
$144,000 30 Sep 2022
13F
JPMORGAN CHASE & CO
13F
Company
0.04%
69,734
$133,000 30 Sep 2022
13F
PEAK6 Investments LLC
13F
Company
0.03%
62,400
$119,000 30 Sep 2022
13F
MetLife Investment Management, LLC
13F
Company
0.03%
58,456
$111,651 30 Sep 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.03%
55,089
$105,000 30 Sep 2022
13F
Rafferty Asset Management, LLC
13F
Company
0.03%
54,329
$104,000 30 Sep 2022
13F
LMR Partners LLP
13F
Company
0.03%
53,940
$103,000 30 Sep 2022
13F
PRELUDE CAPITAL MANAGEMENT, LLC
13F
Company
0.03%
53,877
$103,000 30 Sep 2022
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.03%
51,269
$98,000 30 Sep 2022
13F
DEUTSCHE BANK AG\
13F
Company
0.03%
49,541
$94,000 30 Sep 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.02%
45,660
$87,000 30 Sep 2022
13F
ETF MANAGERS GROUP, LLC
13F
Company
0.02%
44,250
$85,000 30 Sep 2022
13F
VIRTUS ADVISERS, LLC
13F
Company
0.02%
42,988
$82,000 30 Sep 2022
13F

Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q4 2022

As of 31 Dec 2022, Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by 110 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,227,682 shares. The largest 10 holders included BlackRock Inc., Two Seas Capital LP, VANGUARD GROUP INC, Hudson Bay Capital Management LP, Whitefort Capital Management, LP, Rubric Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, FourWorld Capital Management LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 110 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
121
Q4 2022 holders
110
Holder diff
-11
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 Value $ Q4 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .